EXHIBIT 10.1
BridgeBio Pharma, Inc.
Exhibit 10.1
EXECUTION VERSION
CERTAIN INFORMATION IDENTIFIED BY “[***]” HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
INVESTMENT AGREEMENT
dated as of July 1, 2026
by and among
BridgeBio Pharma, Inc.
and
the Purchasers identified herein
TABLE OF CONTENTS
Page
ARTICLE I
PURCHASE; CLOSING
Section 1.1
Purchase
1
Section 1.2
Closing
1
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Section 2.1
Organization and Authority
2
Section 2.2
Capitalization
2
Section 2.3
Authorization
3
Section 2.4
Sale and Status of Securities
4
Section 2.5
SEC Documents; Financial Statements
5
Section 2.6
Undisclosed Liabilities
5
Section 2.7
Absence of Changes
5
Section 2.8
Brokers and Finders
6
Section 2.9
Registration Rights
6
Section 2.10
Compliance with Laws; Anti-Corruption; Trade Controls
6
Section 2.11
Listing and Maintenance Requirements
7
…